Oct 7 (Reuters) – Xintela AB: * TARGINTA COLLABORATES WITH MSK FOR ANTIBODY DEVELOPMENT Source text: Further company coverage: (Gdansk Newsroom)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)